Thus, there is an urgent need to examine the efficacy, selectivity, and mechanisms by which both natural and synthetic cannabinoids exert their analgesic effects in animal models, and validate the analgesic potential of synthetic CB1/2-selective agents in cancer patients. Here, CNR1 is linked to cancer.